Humana (HUM) Fundamental Analysis: Revenue, Earnings & Valuation

4.52 / 10

Netural

Fundamentally, HUM scores around 4.5/10, indicating a moderate profile. Strengths lie in PB‑ROE and cash‑up metrics, while revenue‑to‑market and YoY profit growth lag. Overall, the fundamentals suggest cautious consideration.

Analysis Checks(5/10)

Revenue-MV

Value2.52

Score1/3

Weight6.34%

1M Return1.38%

Net cash flow from operating activities per share (YoY growth rate %)

Value-68.94

Score1/3

Weight9.09%

1M Return1.82%

PB-ROE

Value-0.43

Score3/3

Weight38.05%

1M Return7.08%

Basic earnings per share (YoY growth rate %)

Value-1.40

Score2/3

Weight8.55%

1M Return1.71%

Total profit (YoY growth rate %)

Value-10.69

Score1/3

Weight9.94%

1M Return1.90%

Cash-UP

Value-0.16

Score2/3

Weight7.81%

1M Return1.24%

Diluted earnings per share (YoY growth rate %)

Value-1.40

Score2/3

Weight7.52%

1M Return1.50%

Asset-MV

Value-0.55

Score0/3

Weight-1.59%

1M Return-0.40%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-1.57

Score2/3

Weight21.68%

1M Return4.10%

Cash-MV

Value0.02

Score0/3

Weight-7.38%

1M Return-1.92%

Is HUM undervalued or overvalued?

HUM scores 4.52/10 on fundamentals and holds a Fair valuation at present. Backed by its 6.95% ROE, 0.93% net margin, 17.40 P/E ratio, 1.17 P/B ratio, and -1.40% earnings growth, these metrics solidify its Netural investment rating.